Li-ru R. He

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.

Journal: Cell reports. Medicine

Published: September 24, 2025

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay.

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay.

Journal: ESMO open

Published: January 23, 2025

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Journal: International immunopharmacology

Published: May 08, 2024

Corrigendum to "The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Corrigendum to "The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Journal: Cancer letters

Published: August 06, 2021

Corrigendum to ‟The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Corrigendum to ‟The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].

Journal: Cancer letters

Published: June 06, 2021

Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma.

Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma.

Journal: Radiation oncology (London, England)

Published: April 25, 2021

Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy.

Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy.

Journal: World journal of urology

Published: March 03, 2021

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience.

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience.

Journal: Radiation oncology (London, England)

Published: July 02, 2020

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC.

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC.

Journal: Signal transduction and targeted therapy

Published: May 01, 2020

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients.

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients.

Journal: Radiation oncology (London, England)

Published: July 04, 2019

Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.

Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.

Journal: Radiation oncology (London, England)

Published: October 22, 2018

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

Journal: Cell death & disease

Published: September 04, 2018

Showing 1-12 of 30

Last Updated: 09/26/2026